Critical Care Admission of an HIV Patient with Diabetic Ketoacidosis Secondary to Pembrolizumab

Article

Abstract: Background. Pembrolizumab is a checkpoint inhibitor that targets the programmed cell death-1 recepto

Palabras claves:

Autores:

Botz G.H., John A. Cuenca, Laserna A., Nates J.L., Reyes M.P.

Fuentes:

scopus